Psykey, Inc. (OTCMKTS:CEOS) Short Interest Down 92.0% in July

Psykey, Inc. (OTCMKTS:CEOS) saw a significant drop in short interest in the month of July. As of July 31st, there was short interest totaling 2,400 shares, a drop of 92.0% from the July 15th total of 29,822 shares. Based on an average daily trading volume, of 161,424 shares, the days-to-cover ratio is currently 0.0 days.

Psykey Stock Performance

Shares of Psykey stock remained flat at $0.01 during trading hours on Thursday. 2,200 shares of the company’s stock were exchanged, compared to its average volume of 180,128. The company’s fifty day simple moving average is $0.01 and its 200 day simple moving average is $0.01. Psykey has a 1-year low of $0.00 and a 1-year high of $0.01.

Psykey Company Profile

Psykey, Inc engages in the research, development, and commercialization of entheogenic, adaptogenic, and nootropic ingredients and formulations for its functional product lines to improve and optimize life. The company also engages in the development of technologies for the composition, bioavailability, and targeted delivery of entheogen-based therapeutics for the psychedelic market. Its retail products include functional mushroom coffees and teas, oral supplements, and single serve drink mixes. The company was formerly known as CeCors, Inc and changed its name to Psykey, Inc in August 2021.